Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus

By Chinsangaram J.   Mason P.W.   Grubman M.J.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1516-1522

Elsevier

Access to resources Recommend Favorite

The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves

By West K.   Petrie L.   Konoby C.   Haines D.M.   Cortese V.   Ellis J.A.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 907-919

Elsevier

Access to resources Recommend Favorite

Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines

By Velzing J.   Groen J.   Drouet M.T.   van Amerongen G.   Copra C.   Osterhaus A.D.M.E.   Deubel V.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1312-1320

Elsevier

Access to resources Recommend Favorite

Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine

By Bosch J.C.   Kaashoek M.J.   van Oirschot J.T.  

Vaccine, Vol. 15, Iss. 14, 1997-10 ,pp. : 1512-1517

Elsevier

Access to resources Recommend Favorite

Live attenuated vaccines against influenza; an historical review

By Wareing M.D.   Tannock G.A.  

Vaccine, Vol. 19, Iss. 25, 2001-05 ,pp. : 3320-3330

Elsevier

Access to resources Recommend Favorite